Colgate-Palmolive Company CL
Set alert
95.98 USD -1.45 -1.49%
As of Nov 3, 2:33 PM ET
95.60 Day range 96.90
74.98 52-week range 99.14
- YTD
- +21.46%
- 1 year
- +28.01%
- Open
- 96.76
- Prev close
- 97.43
- Mkt cap
- 76.30B
- Vol
- 2.45M
- Avg vol
- 4.82M
- EPS
- 2.57
- P/E
- 37.35
- Div yield
- 2.28%
More statistics
- Low
- 95.60
- High
- 96.90
- Forward P/E
- 23.76
- Beta
- 0.31
- Short ratio
- 3.19
- Inst. own
- 86.63%
- Dividend
- 2.12
- Ex-div date
- Oct 19, 2026
- Earnings
- Jan 29, 2027
- 50-d avg
- 89.56
- 200-d avg
- 89.68
- 1y target
- 99.65
3M chart
Events in this range
- Oct 20, 2026Dividend: 0.53
- Oct 30, 2026Earnings: 0.97; estimate 0.926; surprise 4.75%
- Nov 2, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Nov 2, 2026Rating: RBC Capital · Outperform → Outperform
- Nov 2, 2026Rating: JP Morgan · Overweight → Overweight
- Nov 2, 2026Rating: TD Cowen · Hold → Hold
- Nov 2, 2026Rating: BNP Paribas · Outperform → Outperform
- Nov 2, 2026Rating: Morgan Stanley · Overweight → Overweight
Signals (25)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 22, 2026 | 1 week ago |
| RSI: Overbought | Oct 20, 2026 | 2 weeks ago |
| RSI: Overbought | Oct 16, 2026 | 2 weeks ago |
| RSI: Overbought | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 4 weeks ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
Newest 20 of 25.
Financial health
Altman Z-Score
7.07 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
9 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 2
- P/B 1
Valuation
P/E 29.9×
FY 2016 5y median 29.9× FY 2025
P/S 3.1×
FY 2016 5y median 3.7× FY 2025
P/B 1183×
FY 2016 5y median 164× FY 2025
P/FCF 17.6×
FY 2016 5y median 21.7× FY 2025
EV/EBITDA 14.6×
FY 2016 5y median 17.4× FY 2025
EV/Sales 3.5×
FY 2016 5y median 4.1× FY 2025
FCF Yield 5.7%
FY 2016 5y median 4.6% FY 2025
Profitability
Gross Margin 60.1%
FY 2016 5y median 59.1% FY 2025
Operating Margin 16.2%
FY 2016 5y median 21.2% FY 2025
Net Margin 10.5%
FY 2016 5y median 11.8% FY 2025
ROE 3948.1%
FY 2016 5y median 445.1% FY 2025
ROIC 22.8%
FY 2016 5y median 24.8% FY 2025
ROA 13.1%
FY 2016 5y median 14.0% FY 2025
Growth (YoY)
Revenue 1.4%
FY 2016 FY 2025
Operating Income -24.6%
FY 2016 FY 2025
EPS (diluted) -25.1%
FY 2016 FY 2025
Free Cash Flow 2.5%
FY 2016 FY 2025
Financial Health
Current Ratio 0.8×
FY 2016 5y median 1.1× FY 2025
Quick Ratio 0.5×
FY 2016 5y median 0.7× FY 2025
Debt / Equity 158×
FY 2016 5y median 23.1× FY 2025
Net Debt / EBITDA 1.5×
FY 2016 5y median 1.9× FY 2025
Interest Coverage 12.4×
FY 2016 5y median 15.0× FY 2025
Dividends
Dividend Yield 2.9%
FY 2016 5y median 2.6% FY 2025
Payout Ratio 85.5%
FY 2016 5y median 77.5% FY 2025
Annual · latest fiscal year ends 2025-12-31
